Sirnaomics

In News

Sirnaomics Moves to Replace 2022 Equity Plan With New 2026 Share Option Scheme - TipRanks

TipRanks - Apr 22, 2026

Sirnaomics Secures HKD 138 Million Strategic Investment from Bloomage Biotech - BioPharma APAC

BioPharma APAC - Sep 09, 2025

SIRNAOMICS-B (02257) has dropped 5.156%. The last price is HK$6.07AA Market Move - All Category - AASTOCKS.com

AASTOCKS.com - May 04, 2026

Opening new frontiers in immuno-oncology with RNAi therapeutics - Nature

Nature - Sep 03, 2022

Sirnaomics completes IND-enabling trials of siRNA therapy STP125G - Clinical Trials Arena

Clinical Trials Arena - Jul 15, 2024

Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Development - PR Newswire

PR Newswire - Apr 21, 2021

Clifford Chance advises Sirnaomics on its Chapter 18A Hong Kong IPO and listing - Clifford Chance

Clifford Chance - Dec 30, 2021

Sirnaomics’ RNAi treatment shows novel mechanism of action for solid tumors - The Pharma Letter

The Pharma Letter - Jan 24, 2024

Sirnaomics nabs a major $105M funding round for next stage of its RNA work - Fierce Biotech

Fierce Biotech - Oct 23, 2020

Sirnaomics starts 2022 with $64M Hong Kong IPO - BioWorld News

BioWorld News - Jan 04, 2022

Sirnaomics to Present at Medical Dermatology Summit - The Herald-Mail

The Herald-Mail - Feb 02, 2021

Sirnaomics: a unique, clinical-phase RNA therapeutic innovator on the global stage - Nature

Nature - May 16, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment